Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Corbett

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Nature Reviews. Drug Discovery|November 6, 2012
Drug repositioning for Alzheimer's diseaseAnne Corbett, James Pickett, Alistair Burns, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 20, 2023
Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trialJoanne McDermid, William Henley, Anne Corbett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersHanna Huber, Wagner Scheeren Brum, Laia Montoliu-Gaya, et al.
Food & Function|May 14, 2025
Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional declineMary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Food & Function|June 9, 2025
Correction: Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional declineMary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Health Technology Assessment (Winchester, England)|March 19, 2019
Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCTLinda Clare, Aleksandra Kudlicka, Jan R Oyebode, et al.
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Journal of Neuroinflammation|November 22, 2023
Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challengeOliver Cousins, Julia J Schubert, Avinash Chandra, et al.
Alzheimer'S Research & Therapy|November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultationAnne Corbett, Janet Sultana, Kate Stych, et al.
Trials|June 26, 2016
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trialClaire A Surr, Rebecca E A Walwyn, Amanda Lilley-Kelly, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Nature Reviews. Drug Discovery|November 6, 2012
Drug repositioning for Alzheimer's diseaseAnne Corbett, James Pickett, Alistair Burns, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 20, 2023
Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trialJoanne McDermid, William Henley, Anne Corbett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersHanna Huber, Wagner Scheeren Brum, Laia Montoliu-Gaya, et al.
Food & Function|May 14, 2025
Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional declineMary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Food & Function|June 9, 2025
Correction: Effects of the DailyColors™ polyphenol supplement on serum proteome, cognitive function, and health in older adults at risk of cognitive and functional declineMary O'Leary, Joanna L Bowtell, Megan Richards, et al.
Health Technology Assessment (Winchester, England)|March 19, 2019
Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCTLinda Clare, Aleksandra Kudlicka, Jan R Oyebode, et al.
Trials|July 20, 2016
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocolCaroline Greenan, Lynn Murphy, Ly-Mee Yu, et al.
Journal of Neuroinflammation|November 22, 2023
Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challengeOliver Cousins, Julia J Schubert, Avinash Chandra, et al.
Alzheimer'S Research & Therapy|November 18, 2025
Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultationAnne Corbett, Janet Sultana, Kate Stych, et al.
Trials|June 26, 2016
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trialClaire A Surr, Rebecca E A Walwyn, Amanda Lilley-Kelly, et al.
Pageof 19